Login / Signup
Dalia S El-Gamil
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Drug Delivery
Squamous Cell
Cell Migration
Childhood Cancer
Top Venues
Future medicinal chemistry
Medicinal research reviews
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yara A Abd El-Rahman
,
Po-Jen Chen
,
Ahmed K ElHady
,
Shun-Hua Chen
,
Hsin-Chieh Lin
,
Dalia S El-Gamil
,
Youssef Aboushady
,
Ashraf H Abadi
,
Matthias Engel
,
Mohammad Abdel-Halim
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity.
Future medicinal chemistry
16 (12) (2024)
Yara A Abd El-Rahman
,
Po-Jen Chen
,
Ahmed K ElHady
,
Shun-Hua Chen
,
Hsin-Chieh Lin
,
Dalia S El-Gamil
,
Youssef Aboushady
,
Ashraf H Abadi
,
Matthias Engel
,
Mohammad Abdel-Halim
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity.
Future medicinal chemistry
16 (12) (2024)
Yara A Abd El-Rahman
,
Po-Jen Chen
,
Ahmed K ElHady
,
Shun-Hua Chen
,
Hsin-Chieh Lin
,
Dalia S El-Gamil
,
Youssef Aboushady
,
Ashraf H Abadi
,
Matthias Engel
,
Mohammad Abdel-Halim
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity.
Future medicinal chemistry
16 (12) (2024)
Ahmed K ElHady
,
Dalia S El-Gamil
,
Ashraf H Abadi
,
Mohammad Abdel-Halim
,
Matthias Engel
An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications.
Medicinal research reviews
(2022)